First Trust NYSE Arca Biotechnology Index Fund FBT
275.07 USD +3.48 (+1.28%)
At closeNov 11, 2026, 4:00 PM EST
272.66 -2.41 -0.88%
After hours · Nov 11, 4:00 PM ET
271.51 Day range 275.54
189.47 52-week range 283.21
- YTD
- +33.19%
- 1 year
- +36.21%
- Market cap
- 1.71B
- EPS (ttm)
- 9.75
- P/E ratio
- 28.20
- YTD return
- +33.19%
- 1-year return
- +36.21%
- Volume
- 45.47K
- Avg volume
- 65.45K
- Open
- 271.56
- Previous close
- 271.59
- Day's range
- 271.51 – 275.54
- 52-week range
- 189.47 – 283.21
5D +1.49 (+0.54%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 269.34
- 200-day average
- 234.92
Next earnings
Consensus EPS estimate 0.00.
About First Trust NYSE Arca Biotechnology Index Fund
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.
News
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? 
Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street’s XPH or First Trust’s FBT? 
Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT? 
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets 
Why Is Natera Stock Gaining Tuesday? 
Moderna's Legal Hit Steals Spotlight From Strong Sales 
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars 
Moderna, Mexico Partner To Boost Local Vaccine Production 
Moderna (MRNA) Stock Pulls Back After Recent Strength 
Moderna Stock Explodes To New 52-Week High: What's Driving The Action?
Your note
Sign in to keep a note on FBT — it syncs with the Stock Master app.